HATAKEYAMA; Shinji

Patent Applications and Registrations

Patent applications and USPTO patent grants for HATAKEYAMA; Shinji.The latest application filed is for "uses of myostatin antagonists, combinations containing them and uses thereof".

Company Profile

3.14.25

HATAKEYAMA; Shinji - Basel CH
Hatakeyama; Shinji - Ibaraki JP
Hatakeyama; Shinji - Ushiku JP
Hatakeyama, Shinji - Tokorozawa-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses Of Myostatin Antagonists, Combinations Containing Them And Uses Thereof App 20220265823 - HATAKEYAMA; Shinji ; et al.	2022-08-25
Uses of myostatin antagonists, combinations containing them and uses thereof Grant 11,357,851 - Hatakeyama , et al. June 14, 2	2022-06-14
Uses Of Myostatin Antagonists, Combinations Containing Them And Uses Thereof App 20200254090 - Kind Code	2020-08-13
Methods For Preventing And Treating Urinary Incontinence App 20200181271 - HATAKEYAMA; Shinji ; et al.	2020-06-11
Benzothiazolone compound Grant 10,251,868 - Cao , et al.	2019-04-09
Benzothiazolone Compound App 20180140582 - CAO; Jun ; et al.	2018-05-24
Benzothiazolone compound Grant 9,913,828 - Cao , et al. March 13, 2	2018-03-13
Formulation comprising benzothiazolone compound Grant 9,623,012 - Achour , et al. April 18, 2	2017-04-18
Benzothiazolone Compound App 20160279107 - CAO; Jun ; et al.	2016-09-29
Method for treating metabolic disorders by administration of an anti-ActRIIB antibody Grant 9,365,651 - Feige , et al. June 14, 2	2016-06-14
Benzothiazolone Compound App 20160075670 - CAO; Jun ; et al.	2016-03-17
Formulation comprising benzothiazolone compound App 20160000761 - ACHOUR; Miloud ; et al.	2016-01-07
Benzothiazolone Compound App 20150336914 - CAO; Jun ; et al.	2015-11-26
Benzothiazolone Compound App 20150094346 - CAO; Jun ; et al.	2015-04-02
Benzothiazolone compound Grant 8,933,108 - Cao , et al. January 13, 2	2015-01-13
Method for Treating Metabolic Disorders App 20140328848 - Feige; Jerome ; et al.	2014-11-06
Benzothiazolone Compound App 20130245080 - CAO; Jun ; et al.	2013-09-19
1,2-dihydropyridine Compounds, Manufacturing Method Thereof And Use Thereof App 20090275751 - NAGATO; Satoshi ; et al.	2009-11-05
1,2-dihydropyridine compounds, manufacturing method thereof and use thereof Grant 7,563,811 - Nagato , et al. July 21, 2	2009-07-21
Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations App 20060189622 - Nagato; Satoshi ; et al.	2006-08-24
N-calcium channel knockout animal Grant 7,067,714 - Ino , et al. June 27, 2	2006-06-27
1, 2-Dihydropyridine compounds, manufacturing method thereof and use thereof App 20050245581 - Nagato, Satoshi ; et al.	2005-11-03
1,2-dihydropyridine compounds, process for preparation of the same and use thereof Grant 6,949,571 - Nagato , et al. September 27, 2	2005-09-27
Piperazine compound and pharmaceutical composition containing the compound Grant 6,906,072 - Yamamoto , et al. June 14, 2	2005-06-14
Information recording/reproduction apparatus, information recording/reproduction program and an information recording medium on which the information recording/reproduction program is recorded App 20050094986 - Miyazaki, Seiji ; et al.	2005-05-05
Heterodiazinone derivatives Grant 6,825,192 - Ito , et al. November 30, 2	2004-11-30
Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound App 20040220193 - Yamamoto, Noboru ; et al.	2004-11-04
N,N-substituted cyclic amine derivatives Grant 6,737,425 - Yamamoto , et al. May 18, 2	2004-05-18
1,2-Dihydropyridine compounds, process for preparation of the same and use thereof App 20040023973 - Nagato, Satoshi ; et al.	2004-02-05
Pyridazinones and triazinones and medicinal use thereof App 20030225081 - Nagato, Satoshi ; et al.	2003-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.